819075-43-9 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
Urea, N'-[[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-N,N-diethylis utilized as a research compound for the development of new pharmaceuticals targeting neurological disorders and psychiatric illnesses. Its interaction with central nervous system receptors makes it a promising candidate for the treatment of various medical conditions.
Used in the Treatment of Neurological Disorders:
In the field of neurology, Urea, N'-[[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-N,N-diethylis used as a potential therapeutic agent for the treatment of neurological disorders. Its specific interaction with receptors in the central nervous system may contribute to the management or mitigation of symptoms associated with these conditions.
Used in the Treatment of Psychiatric Illnesses:
Similarly, in psychiatry, Urea, N'-[[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-N,N-diethyl- is used as a potential therapeutic agent for the treatment of psychiatric illnesses. Its ability to modulate receptor activity in the central nervous system may offer new avenues for the management of mental health conditions.
It is crucial to handle Urea, N'-[[1,4-bis(phenylmethyl)-2-piperazinyl]methyl]-N,N-diethylwith care and follow safety guidelines, as it may possess toxic or hazardous properties. Further research and development are necessary to fully understand its potential applications and ensure its safe use in medical treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 819075-43-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,1,9,0,7 and 5 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 819075-43:
(8*8)+(7*1)+(6*9)+(5*0)+(4*7)+(3*5)+(2*4)+(1*3)=179
179 % 10 = 9
So 819075-43-9 is a valid CAS Registry Number.
819075-43-9Relevant academic research and scientific papers
Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity
Serradji, Nawal,Martin, Marc,Bensaid, Okkacha,Cisternino, Salvatore,Rousselle, Christophe,Dereuddre-Bosquet, Nathalie,Huet, Jack,Redeuilh, Catherine,Lamouri, Aazdine,Dong, Chang-Zhi,Clayette, Pascal,Scherrmann, Jean-Michel,Dormont, Dominique,Heymans, Fran?oise
, p. 6410 - 6419 (2007/10/03)
The HIV-1 central nervous system infection leads to the onset of neurological impairments called AIDS dementia complex (ADC). PAF plays an important role in this pathology, as it is an HIV-1-induced neurotoxin produced by infected or activated macrophages
